{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:59:10Z","timestamp":1795053550185,"version":"4.10.2"},"reference-count":90,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BIBLIOSAN"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GlaxoSmithKline Experimental Medicine Initiative to Explore New Therapies"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biomedical Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lymphadenopathy is a common clinical finding and diagnostic challenge within general medicine and rheumatology practice. It may represent a primary manifestation of an underlying immune-mediated disease or indicate an infectious or neoplastic complication requiring differing management. Evaluating lymphadenopathy is of particular relevance in rheumatology, given that lymph node enlargement is a common finding within the clinical spectrum of several well-known rheumatologic disorders including RA, SLE and SS. In addition, lymphadenopathy represents a hallmark manifestation of rare immunological diseases such as Castleman disease and IgG4-related disease that must be considered in the differential diagnosis because effective targeted treatments can now impact the prognosis of these conditions. In this review we present an overview of the clinical significance of lymphadenopathy in common and rare rheumatologic diseases and propose a practical approach to lymphadenopathy in the rheumatology practice. Differential diagnosis of Castleman disease and therapeutic options for this condition of increasing rheumatologic interest will be discussed in detail.<\/jats:p>","DOI":"10.1093\/rheumatology\/kead644","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T12:12:52Z","timestamp":1702555972000},"page":"1484-1493","source":"Crossref","is-referenced-by-count":33,"title":["Lymphadenopathy in the rheumatology practice: a pragmatic approach"],"prefix":"10.1093","volume":"63","author":[{"given":"Stefano","family":"Rodolfi","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital , Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Della-Torre","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute , Milan, Italy"},{"name":"Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR) , Milan, Italy"},{"name":"IRCCS San Raffaele Scientific Institute , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Bongiovanni","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Vita-Salute San Raffaele, IRCCS San Raffaele Scientific Institute , Milan, Italy"},{"name":"Department of Haematopathology Diagnostic Area, Unit of Pathology, IRCCS San Raffaele Scientific Institute , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-9306","authenticated-orcid":false,"given":"Puja","family":"Mehta","sequence":"additional","affiliation":[{"name":"Division of Medicine, University College, Centre for Inflammation and Tissue Repair, UCL Respiratory , London"},{"name":"Department of Rheumatology, University College London Hospital (UCLH) , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Fajgenbaum","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Translational Medicine and Human Genetics, Center for Cytokine Storm Treatment and Laboratory , Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0323-0376","authenticated-orcid":false,"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital , Milan, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"2024060322015851300_kead644-B1","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJM198411293112204","article-title":"A prospective clinical and immunologic analysis of patients with serum sickness","volume":"311","author":"Lawley","year":"1984","journal-title":"N Engl J Med"},{"key":"2024060322015851300_kead644-B2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.semarthrit.2015.06.014","article-title":"Rituximab-induced serum sickness: a systematic review","volume":"45","author":"Karmacharya","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"2024060322015851300_kead644-B3","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1592\/phco.26.5.705","article-title":"Severe serum sickness reaction to oral and intramuscular penicillin","volume":"26","author":"Clark","year":"2006","journal-title":"Pharmacotherapy"},{"key":"2024060322015851300_kead644-B4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1525-1470.2011.01539.x","article-title":"Serum sickness-like reaction in children due to cefditoren","volume":"29","author":"Misirlioglu","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"2024060322015851300_kead644-B5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.15614","article-title":"Diagnosis of Hodgkin lymphoma in the modern era","volume":"184","author":"Wang","year":"2019","journal-title":"Br J Haematol"},{"key":"2024060322015851300_kead644-B6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"2024060322015851300_kead644-B7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1634\/theoncologist.2011-0075","article-title":"Castleman\u2019s disease: systematic analysis of 416 patients from the literature","volume":"16","author":"Talat","year":"2011","journal-title":"Oncologist"},{"key":"2024060322015851300_kead644-B8","first-page":"896","article-title":"Unexplained Lymphadenopathy: evaluation and Differential Diagnosis","volume":"94","author":"Gaddey","year":"2016","journal-title":"Am Fam Physician"},{"key":"2024060322015851300_kead644-B9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/sj.bjc.6600738","article-title":"Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients","volume":"88","author":"Chau","year":"2003","journal-title":"Br J Cancer"},{"key":"2024060322015851300_kead644-B10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.semdp.2012.07.001","article-title":"Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity","volume":"29","author":"Cheuk","year":"2012","journal-title":"Semin Diagn Pathol"},{"key":"2024060322015851300_kead644-B11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF02230354","article-title":"Lymphadenopathy in systemic lupus erythematosus. Prevalence and relation to disease manifestations","volume":"15","author":"Shapira","year":"1996","journal-title":"Clin Rheumatol"},{"key":"2024060322015851300_kead644-B12","first-page":"73","article-title":"The lymph nodes in disseminated lupus erythematosus","volume":"19","author":"Fox","year":"1943","journal-title":"Am J Pathol"},{"key":"2024060322015851300_kead644-B13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/147323000303100415","article-title":"Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus","volume":"31","author":"\u00c7alg\u00fcneri","year":"2003","journal-title":"J Int Med Res"},{"key":"2024060322015851300_kead644-B14","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B15","first-page":"e15517","article-title":"Systemic lupus erythematosus with multi-organ involvement in a young female: lymphadenopathy, lupus cerebritis, lupus nephritis, and cardiac manifestations","volume":"13","author":"Muhammad","year":"2021","journal-title":"Cureus"},{"key":"2024060322015851300_kead644-B16","first-page":"e30089","article-title":"Generalized lymphadenopathy as the first manifestation of systemic lupus erythematosus","volume":"14","author":"Soares","year":"2022","journal-title":"Cureus"},{"key":"2024060322015851300_kead644-B17","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2174\/1573397117666210902151130","article-title":"Lymphadenopathy as a prodrome for systemic lupus erythematous","volume":"17","author":"Kinariwalla","year":"2021","journal-title":"Curr Rheumatol Rev"},{"key":"2024060322015851300_kead644-B18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1749-6632.2011.06076.x","article-title":"PET\/CT imaging in systemic lupus erythematosus","volume":"1228","author":"Curiel","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"2024060322015851300_kead644-B19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s13139-017-0471-z","article-title":"Systemic lupus erythematosus associated pitfalls on 18F-FDG PET\/CT: reactive follicular hyperplasia, kikuchi-fujimoto disease, inflammation and lymphoid hyperplasia of the spleen mimicking lymphoma","volume":"52","author":"Makis","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"2024060322015851300_kead644-B20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.prp.2007.03.002","article-title":"Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients","volume":"203","author":"Kojima","year":"2007","journal-title":"Pathol Res Pract"},{"key":"2024060322015851300_kead644-B21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00296-020-04684-4","article-title":"Systemic lupus erythematosus complicated with Castleman disease: a case-based review","volume":"41","author":"Demirkan","year":"2021","journal-title":"Rheumatol Int"},{"key":"2024060322015851300_kead644-B22","first-page":"402","article-title":"The clinical importance of lymphadenopathy in systemic lupus erythematosus","volume":"33","author":"Melikoglu","year":"2008","journal-title":"Acta Reumatol Port"},{"key":"2024060322015851300_kead644-B23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s10067-004-0923-6","article-title":"Kikuchi-Fujimoto\u2019s disease associated with systemic lupus erythematosus: case report and review of the literature","volume":"24","author":"Santana","year":"2005","journal-title":"Clin Rheumatol"},{"key":"2024060322015851300_kead644-B24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/ard.46.8.645","article-title":"Lymphadenopathy in rheumatic patients","volume":"46","author":"Hart","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcdb.2015.01.001","article-title":"The role of the lymphatic system in inflammatory-erosive arthritis","volume":"38","author":"Bouta","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"2024060322015851300_kead644-B26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.083394","article-title":"Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints","volume":"67","author":"Polzer","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4103\/ijnm.ijnm_57_21","article-title":"Rheumatoid arthritis with generalized lymphadenopathy mimicking lymphoma on positron emission tomography\/computed tomography with 18F-fluorodeoxyglucose","volume":"36","author":"Filippi","year":"2021","journal-title":"Indian J Nucl Med"},{"key":"2024060322015851300_kead644-B28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/ard.46.8.645","article-title":"Lymphadenopathy in rheumatic patients","volume":"46","author":"Hart","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clinimag.2019.02.014","article-title":"Mediastinal and axillar lymphadenopathy in patients with rheumatoid arthritis: prevalence and clinical significance","volume":"55","author":"Okabe","year":"2019","journal-title":"Clin Imaging"},{"key":"2024060322015851300_kead644-B30","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00296-018-3992-6","article-title":"CT assessment of axillary lymphadenopathy in patients with rheumatoid arthritis: association with disease activity and severity","volume":"38","author":"Hasegawa","year":"2018","journal-title":"Rheumatol Int"},{"key":"2024060322015851300_kead644-B31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13075-016-1142-7","article-title":"Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors","volume":"18","author":"Manzo","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2024060322015851300_kead644-B32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1148\/rg.2020190047","article-title":"Fluorodeoxyglucose PET\/CT of arthritis in rheumatic diseases: a pictorial review","volume":"40","author":"Hotta","year":"2020","journal-title":"Radiographics"},{"key":"2024060322015851300_kead644-B33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4103\/ijnm.ijnm_57_21","article-title":"Rheumatoid arthritis with generalized lymphadenopathy mimicking lymphoma on positron emission tomography\/computed tomography with 18F-fluorodeoxyglucose","volume":"36","author":"Filippi","year":"2021","journal-title":"Indian J Nucl Med"},{"key":"2024060322015851300_kead644-B34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.semdp.2017.11.015","article-title":"Autoimmune and medication-induced lymphadenopathies","volume":"35","author":"Gru","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"2024060322015851300_kead644-B35","doi-asserted-by":"crossref","first-page":"20584601221112616","DOI":"10.1177\/20584601221112616","article-title":"Comparison of the axillary lymph node between rheumatoid arthritis and psoriatic arthritis with computed tomography","volume":"11","author":"Fukuda","year":"2022","journal-title":"Acta Radiol Open"},{"key":"2024060322015851300_kead644-B36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0046-8177(90)90004-O","article-title":"Nodal and extranodal lymphoproliferative disorders in Sjogren\u2019s syndrome: a clinical and immunopathologic study","volume":"21","author":"McCurley","year":"1990","journal-title":"Hum Pathol"},{"key":"2024060322015851300_kead644-B37","doi-asserted-by":"crossref","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine"},{"key":"2024060322015851300_kead644-B38","first-page":"2357","article-title":"The clinical phenotype of primary Sj\u00f6gren\u2019s syndrome patients with lymphadenopathy","volume":"40","author":"Stergiou","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2024060322015851300_kead644-B39","doi-asserted-by":"crossref","first-page":"553.1","DOI":"10.1136\/annrheumdis-2016-eular.4517","article-title":"FRI0326 peripheral lymphadenopathy in primary Sj\u00f6gren\u2019s syndrome: frequency, pattern of distribution and clinical significance\u2014a single center experience","volume":"75","author":"Elefante","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B40","doi-asserted-by":"publisher","DOI":"10.1136\/RMDOPEN-2014-000022","article-title":"EULAR Sj\u00f6gren\u2019s syndrome disease activity index (ESSDAI): a user guide","volume":"1","author":"Seror","year":"2015","journal-title":"RMD Open"},{"key":"2024060322015851300_kead644-B41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sj\u00f6gren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine"},{"key":"2024060322015851300_kead644-B42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sj\u00f6gren\u2019s syndrome","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"2024060322015851300_kead644-B43","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B44","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"2024060322015851300_kead644-B45","doi-asserted-by":"crossref","first-page":"2001160","DOI":"10.1183\/13993003.01160-2020","article-title":"Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multi-ethnic, multicentre cohort","volume":"57","author":"Lhote","year":"2021","journal-title":"Eur Respir J"},{"key":"2024060322015851300_kead644-B46","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3390\/cells10040766","article-title":"Sarcoidosis: a clinical overview from symptoms to diagnosis","volume":"10","author":"S\u00e8ve","year":"2021","journal-title":"Cells"},{"key":"2024060322015851300_kead644-B47","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.rmed.2012.02.014","article-title":"Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis","volume":"106","author":"Agarwal","year":"2012","journal-title":"Respir Med"},{"key":"2024060322015851300_kead644-B48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jum.15372","article-title":"Identification of specific endobronchial ultrasound features to differentiate sarcoidosis from other causes of lymphadenopathy","volume":"40","author":"Cheng","year":"2021","journal-title":"J Ultrasound Med"},{"key":"2024060322015851300_kead644-B49","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12890-021-01769-z","article-title":"Application of neck ultrasound in the diagnosis of sarcoidosis","volume":"21","author":"Shen","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2024060322015851300_kead644-B50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/LBR.0000000000000588","article-title":"Neck ultrasound for the detection of cervical lymphadenopathy in sarcoidosis: an alternative to endobronchial ultrasound","volume":"26","author":"Ahmed","year":"2019","journal-title":"J Bronchology Interv Pulmonol"},{"key":"2024060322015851300_kead644-B51","first-page":"446","article-title":"Immunoglobulin G4-related disease in Hong Kong: clinical features, treatment practices, and its association with multisystem disease","volume":"23","author":"Li","year":"2017","journal-title":"Hong Kong Med J"},{"key":"2024060322015851300_kead644-B52","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/rheumatology\/keaa648","article-title":"Lymphadenopathy in IgG4-related disease: a phenotype of severe activity and poor prognosis, with eotaxin-3 as a new biomarker","volume":"60","author":"Takanashi","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2024060322015851300_kead644-B53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.path.2015.09.005","article-title":"Immunoglobulin G4-related lymphadenopathy","volume":"9","author":"Bookhout","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"2024060322015851300_kead644-B54","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/j.semdp.2017.11.006","article-title":"Lymphadenopathy associated with IgG4-related disease: diagnosis & differential diagnosis","volume":"35","author":"Wick","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"2024060322015851300_kead644-B56","doi-asserted-by":"crossref","first-page":"m1067","DOI":"10.1136\/bmj.m1067","article-title":"Advances in the diagnosis and management of IgG4 related disease","volume":"369","author":"Lanzillotta","year":"2020","journal-title":"BMJ"},{"key":"2024060322015851300_kead644-B57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"79","author":"Wallace","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2024060322015851300_kead644-B58","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM195409022511008","article-title":"Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot","volume":"251","author":"Cabot","year":"1954","journal-title":"N Engl J Med"},{"key":"2024060322015851300_kead644-B59","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2017.09.001","article-title":"Epidemiology of Castleman disease","volume":"32","author":"Simpson","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"2024060322015851300_kead644-B61","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman\u2019s disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"key":"2024060322015851300_kead644-B62","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s004310051166","article-title":"Paediatric Castleman disease: report of seven cases and review of the literature","volume":"158","author":"Parez","year":"1999","journal-title":"Eur J Pediatr"},{"key":"2024060322015851300_kead644-B63","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<706::AID-CNCR21>3.0.CO;2-7","article-title":"The management of unicentric and multicentric Castleman\u2019s disease: a report of 16 cases and a review of the literature","volume":"85","author":"Bowne","year":"1999","journal-title":"Cancer"},{"key":"2024060322015851300_kead644-B64","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B65","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/modpathol.2013.202","article-title":"Monoclonality and cytogenetic abnormalities in hyaline vascular Castleman disease","volume":"27","author":"Chang","year":"2014","journal-title":"Mod Pathol"},{"key":"2024060322015851300_kead644-B66","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1046\/j.1440-1827.2001.01266.x","article-title":"HHV-8 infection status of AIDS-unrelated and AIDS-associated multicentric Castleman\u2019s disease","volume":"51","author":"Suda","year":"2001","journal-title":"Pathol Int"},{"key":"2024060322015851300_kead644-B67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.hoc.2017.09.002","article-title":"Castleman disease pathogenesis","volume":"32","author":"Fajgenbaum","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"2024060322015851300_kead644-B68","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D'Souza","year":"2011","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/bjh.15921","article-title":"Treatment and outcome of Unicentric Castleman Disease: a retrospective analysis of 71 cases","volume":"186","author":"Boutboul","year":"2019","journal-title":"Br J Haematol"},{"key":"2024060322015851300_kead644-B70","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.15019","article-title":"The full spectrum of Castleman disease: 273 patients studied over 20 years","volume":"180","author":"Oksenhendler","year":"2018","journal-title":"Br J Haematol"},{"key":"2024060322015851300_kead644-B71","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/QAI.0b013e3182a8338f","article-title":"Diagnostic criteria schemes for multicentric Castleman disease in 75 cases","volume":"65","author":"Bower","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2024060322015851300_kead644-B72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","article-title":"POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am J Hematol"},{"key":"2024060322015851300_kead644-B73","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2018-05-848671","article-title":"Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease","volume":"132","author":"Fajgenbaum","year":"2018","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B74","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.24242","article-title":"Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease","volume":"91","author":"Iwaki","year":"2016","journal-title":"Am J Hematol"},{"key":"2024060322015851300_kead644-B75","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.hoc.2017.09.004","article-title":"Pathology of Castleman disease","volume":"32","author":"Wu","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"2024060322015851300_kead644-B76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ajcp\/aqw218","article-title":"HHV8\/KSHV-positive lymphoproliferative disorders and the spectrum of plasmablastic and plasma cell neoplasms: 2015 SH\/EAHP workshop report-part 3","volume":"147","author":"Chadburn","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"2024060322015851300_kead644-B77","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1053\/jpsu.2001.28877","article-title":"Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of Castleman\u2019s disease with respiratory failure requiring lung transplantation","volume":"36","author":"Chin","year":"2001","journal-title":"J Pediatr Surg"},{"key":"2024060322015851300_kead644-B78","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1182\/blood-2016-10-747477","article-title":"Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients","volume":"129","author":"Pria","year":"2017","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B79","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","article-title":"Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman\u2019s disease: ANRS 117 CastlemaB Trial","volume":"25","author":"G\u00e9rard","year":"2007","journal-title":"J Clin Oncol"},{"key":"2024060322015851300_kead644-B80","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","volume":"132","author":"Van Rhee","year":"2018","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B81","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"Van Rhee","year":"2014","journal-title":"Lancet Oncol"},{"key":"2024060322015851300_kead644-B82","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2016-11-748855","article-title":"Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease","volume":"129","author":"Yu","year":"2017","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B83","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1182\/bloodadvances.2022007112","article-title":"Siltuximab is associated with improved progression-free survival in idiopathic multicentric Castleman disease","volume":"6","author":"van Rhee","year":"2022","journal-title":"Blood Adv"},{"key":"2024060322015851300_kead644-B84","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B85","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1158\/1078-0432.CCR-15-0134","article-title":"Analysis of inflammatory and anemia-related biomarkers in a randomized, double-blind, placebo-controlled study of siltuximab (anti-IL6 monoclonal antibody) in patients with multicentric castleman disease","volume":"21","author":"Casper","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2024060322015851300_kead644-B86","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/bjh.15588","article-title":"Predictors of response to anti-IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data","volume":"184","author":"Morra","year":"2019","journal-title":"Br J Haematol"},{"key":"2024060322015851300_kead644-B87","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1182\/bloodadvances.2020004016","article-title":"Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease","volume":"5","author":"Pierson","year":"2021","journal-title":"Blood Adv"},{"key":"2024060322015851300_kead644-B88","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood-2018-07-862334","article-title":"International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease","volume":"132","author":"Van Rhee","year":"2018","journal-title":"Blood"},{"key":"2024060322015851300_kead644-B89","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1136\/jclinpath-2020-206733","article-title":"Rosai-Dorfman disease: an overview","volume":"73","author":"Bruce-Brand","year":"2020","journal-title":"J Clin Pathol"},{"key":"2024060322015851300_kead644-B90","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MD.0000000000000220","article-title":"Kikuchi-Fujimoto disease: retrospective study of 91 cases and review of the literature","volume":"93","author":"Dumas","year":"2014","journal-title":"Medicine"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead644\/54770764\/kead644.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/6\/1484\/58064847\/kead644.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/6\/1484\/58064847\/kead644.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T20:23:56Z","timestamp":1730838236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/6\/1484\/7477667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":90,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,12,18]]},"published-print":{"date-parts":[[2024,5,3]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead644","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6,1]]},"published":{"date-parts":[[2023,12,18]]}}}